fbiA Resolved · high auto-curated

H37Rv Rv3261 · MTBC0 mtbc0_003469 · 331 aa · 3662686–3663681 MTBC0 (+) · RefSeq NP_217778.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)2-phospho-L-lactate transferase
MTBC0 PGAP re-annotation2-phospho-L-lactate transferase
Revised (this work)2-phospho-L-lactate transferase. Pfam: CofD (PF01933.24).
Functional category (TubercuList)intermediary metabolism and respiration

Curation note: 2026-08-26 (feedback from the group's own BPaL/BPaLM resistance-emergence manuscript, mtbc/bpal_resistance_emergence project; submission in preparation for the Journal of Antimicrobial Chemotherapy after a desk-reject by Antimicrobial Agents and Chemotherapy, not yet peer-reviewed). Included in the pathway-wide phylogenetic-convergence scan for phenotype-free pretomanid/delamanid determinants (1,696 non-catalogued candidate positions across the whole F420 pathway), but this locus carries no individually named standout candidate in the current draft. One literature-flagged position, R321S, was explicitly tested and NOT retained: it has a single Iranian carrier, insufficient support under the manuscript's criteria. Full manuscript and code: https://github.com/cguyeux/deciphering-tuberculosis-with-ai/tree/main/bpal_resistance_emergence.

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 25 publications

25 TB publications mention this gene. 25 publications discuss this gene (count verified against title and abstract text). Queried separately, 25 records carry a M. tuberculosis context and 2 a non-TB mycobacterial context (species named in the 2-record verified sample: M. smegmatis (2)). The three counts come from three distinct PubMed queries (the total is text-verified, the context counts are raw query volumes), so they neither partition the total nor need to add up to it.

5 of 25: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Resistance to Linezolid and Pretomanid in the Era of Modern Drug-Resistant Tuberculosis Treatment in South Africa: A Systematic Review and Meta-Analysis. doi:10.3390/antibiotics15060543 2026
Molecular Mechanisms of Resistance and Treatment Efficacy of Delamanid Against Mycobacterium tuberculosis: A Systematic Review. doi:10.1002/hsr2.72481 2026
Delamanid or pretomanid for treatment of multidrug resistant tuberculosis---spoilt for choice? doi:10.1016/j.ijtb.2025.09.005 2026
Spontaneous mutations to delamanid and pretomanid resistance in Mycobacterium tuberculosis: SNPs confer high-level resistance. doi:10.1016/j.ijantimicag.2026.107789 2026
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis. doi:10.1128/aac.01113-25 2025
26 records returned by the alias sweep (a separate sweep from the 25 above; both are shown, neither is exhaustive)

Searched as: Rv3261, fbiA, Mb3289, ML0759c, MMAR_1281, MSMEG_1830, MAB_3607 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
No phenotypic resistance observed for most group-3 and -4 variants in Mycobacterium tuberculosis genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context. doi:10.1128/spectrum.02005-26 Microbiol Spectr 2026
Resistance to Linezolid and Pretomanid in the Era of Modern Drug-Resistant Tuberculosis Treatment in South Africa: A Systematic Review and Meta-Analysis. doi:10.3390/antibiotics15060543 Antibiotics (Basel) 2026
Molecular Mechanisms of Resistance and Treatment Efficacy of Delamanid Against Mycobacterium tuberculosis: A Systematic Review. doi:10.1002/hsr2.72481 Health Sci Rep 2026
Delamanid or pretomanid for treatment of multidrug resistant tuberculosis---spoilt for choice? doi:10.1016/j.ijtb.2025.09.005 Indian J Tuberc 2026
Spontaneous mutations to delamanid and pretomanid resistance in Mycobacterium tuberculosis: SNPs confer high-level resistance. doi:10.1016/j.ijantimicag.2026.107789 Int J Antimicrob Agents 2026
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis. doi:10.1128/aac.01113-25 Antimicrob Agents Chemother 2025
Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran. doi:10.1186/s12866-025-04213-y BMC Microbiol 2025
Computational structure-guided approach to simulate delamanid and pretomanid binding to mycobacterial F420 redox cycling proteins: identification of key determinants of resistance. doi:10.1080/07391102.2025.2498621 J Biomol Struct Dyn 2025
Functional analysis of genetic mutations in ddn and fbiA linked to delamanid resistance in rifampicin-resistant Mycobacterium tuberculosis. doi:10.1016/j.tube.2025.102630 names it Tuberculosis (Edinb) 2025
A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis. doi:10.1002/jcla.25091 J Clin Lab Anal 2024
Investigation of genomic mutations and their association with phenotypic resistance to new and repurposed drugs in Mycobacterium tuberculosis complex clinical isolates. doi:10.1093/jac/dkad252 J Antimicrob Chemother 2023
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice. doi:10.1016/j.ijantimicag.2023.106953 Int J Antimicrob Agents 2023
Emergence of Canonical and Noncanonical Genomic Variants following In Vitro Exposure of Clinical Mycobacterium tuberculosis Strains to Bedaquiline or Clofazimine. doi:10.1128/aac.01368-22 Antimicrob Agents Chemother 2023
Spontaneous Mutational Patterns and Novel Mutations for Delamanid Resistance in Mycobacterium tuberculosis. doi:10.1128/aac.00531-22 Antimicrob Agents Chemother 2022
Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid. doi:10.1038/s41598-021-98862-4 Sci Rep 2021
Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis. doi:10.1128/AAC.01948-20 Antimicrob Agents Chemother 2020
Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. doi:10.1128/AAC.00513-20 Antimicrob Agents Chemother 2020
Recombinant Rv3261 protein of Mycobacterium tuberculosis induces apoptosis through a mitochondrion-dependent pathway in macrophages and inhibits intracellular bacterial growth. doi:10.1016/j.cellimm.2020.104145 names it Cell Immunol 2020
Delamanid Resistance: Update and Clinical Management. doi:10.1093/cid/ciaa755 Clin Infect Dis 2020
Cellular and Structural Basis of Synthesis of the Unique Intermediate Dehydro-F(420)-0 in Mycobacteria. doi:10.1128/mSystems.00389-20 mSystems 2020
Whole Genome Sequencing for the Analysis of Drug Resistant Strains of Mycobacterium tuberculosis: A Systematic Review for Bedaquiline and Delamanid. doi:10.3390/antibiotics9030133 Antibiotics (Basel) 2020
Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis. doi:10.1007/s10096-019-03551-w Eur J Clin Microbiol Infect Dis 2019
Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis. doi:10.1016/j.tube.2017.12.006 Tuberculosis (Edinb) 2018
Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system. doi:10.1093/jac/dkw044 J Antimicrob Chemother 2016
Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis. doi:10.1128/AAC.00308-15 Antimicrob Agents Chemother 2015
Use of transposon Tn5367 mutagenesis and a nitroimidazopyran-based selection system to demonstrate a requirement for fbiA and fbiB in coenzyme F(420) biosynthesis by Mycobacterium bovis BCG. doi:10.1128/JB.183.24.7058-7066.2001 names it J Bacteriol 2001

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourfbiB (Rv3262, + strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index 0.52 (95% CI -1.12 to 3.23). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.306 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=10 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionRequired for coenzyme F420 production: involved in the conversion of FO into F420.
Mycobrowser EC 2.7.8.- · superseded EC numbering; the atlas uses the current class (2.7.8.28)

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3289 · 100.0% identity
M. leprae ML0759c · 79.3% identity
M. marinum MMAR_1281 · 78.7% identity
M. smegmatis MSMEG_1830 · 73.2% identity
M. orygis RJtmp_003361 · 100.0% identity
M. abscessus MAB_3607 · 69.9% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WP81 SwissProt · reviewed · Evidence at protein level
UniProt namePhosphoenolpyruvate transferase
EC (curated) EC 2.7.8.28
Curated functionCatalyzes the transfer of the phosphoenolpyruvate moiety from enoylpyruvoyl-2-diphospho-5'-guanosine (EPPG) to 7,8-didemethyl-8-hydroxy-5-deazariboflavin (FO) with the formation of dehydro coenzyme F420-0 and GMP.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category H Coenzyme transport and metabolism
Preferred namecofD
eggNOG descriptionCatalyzes the transfer of the 2-phospholactate moiety from lactyl (2) diphospho-(5')guanosine (LPPG) to 7,8-didemethyl- 8-hydroxy-5-deazariboflavin (FO) with the formation of the L- lactyl phosphodiester of 7,8-didemethyl-8-hydroxy-5- deazariboflavin (F420-0) and GMP
Orthologous groupCOG0391
EC number EC 2.7.8.28
KEGG orthology K11212
KEGG pathways map00680, map01120
KEGG modules M00378
Gene Ontology (16) GO:0003674, GO:0003824, GO:0006732, GO:0008150, GO:0008152, GO:0009058, GO:0009108, GO:0009987, GO:0016740, GO:0016772, GO:0016773, GO:0043743 +4 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.685 · quasi-invariant (6 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 2 synonymous, 4 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Actinomycetia

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 81.6% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 6/13 non-Mycobacterium reference genomes (down to Actinomycetia) · mean identity 64.3%
detected across the class Actinomycetia (beyond Corynebacteriales) but not outside the phylum — an Actinobacteria-level ancient gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 14 in the ORF — 0 in the essential state, 0 growth-defect, 14 non-essential, 0 growth-advantage. Saturation 1.000, mean read count 58.8571428571. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 14 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
differential fitness in a comparison whose nature could not be established (upstream metadata defect, see note) (undetermined) +5.940.0042 disruption advantageous
fitness in mouse infection, day 45 (in vivo) -5.280.0 required
altered fitness under 6 weeks hypoxia (stress) -4.120.0 required
altered fitness under Isoniazid (drug exposure) +3.610.0 disruption advantageous
fitness in mouse infection (in vivo) +3.610.0 disruption advantageous
fitness in mouse infection (in vivo) +3.520.02 disruption advantageous
fitness in mouse infection (in vivo) +3.440.0068 disruption advantageous
fitness in mouse infection (in vivo) +3.300.0 disruption advantageous
fitness in mouse infection (in vivo) +3.290.027 disruption advantageous
fitness in mouse infection (in vivo) +3.080.031 disruption advantageous
fitness in mouse infection (in vivo) +3.050.0089 disruption advantageous
altered fitness under Isoniazid (drug exposure) +2.990.013 disruption advantageous

Conditional fitness of transposon-disruption mutants across 18 significant condition(s) — the table lists the 12 strongest by |log2FC|, not all 18 (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Provenance note on a condition above. MtbTnDB labels this condition in vivo (Collaborative Cross mouse panel) and attributes it to Smith et al. 2022, eLife 74419. Both are wrong and for the same reason: its left arm, `mbio_H37Rv`, is the saturated H37Rv reference of DeJesus et al. 2017 (mBio 8(1):e02133-16, fourteen independent Tn libraries grown in standard medium), not a mouse strain, and the upstream generator read the token before `_vs_` as a mouse-strain name. The same sample is the in vitro control of six knockout screens in the same file. Measured here on rank correlation over 3971 genes: this condition tracks the other 81 first-order in vivo conditions at rho = +0.03, where those conditions track each other at +0.270 -- it does not behave like an infection measurement. What the comparison actually is could not be established, so it is reported as undetermined rather than renamed, and it is excluded from the in vivo count of this fiche.

Drug resistance (WHO catalogue) delamanid

delamanid87 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 14 of 16 independent MS datasets
Integrated abundance69.2 ppm · rank 1543/3519 (56.2th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length331 aa
Molecular weight35.3 kDa
Theoretical pI5.04
GRAVY0.101 (hydrophobic)
Aliphatic index95.5
Aromaticity0.06
Instability index27.9 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
CofDPF01933.24 2.6e-603–294 2-phospho-L-lactate transferase CofD

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 95.8, very high), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 95.8

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
6uw1-assembly1_B 1.00 0.99 0.95 0.99 71% 100% / 100% 6.4e-56 sig 6uw1-assembly1_B The crystal structure of FbiA from Mycobacterium Smegmatis, Fo bound form
6uw3-assembly1_B 1.00 0.99 0.97 0.99 73% 100% / 100% 6.8e-56 sig 6uw3-assembly1_B The crystal structure of FbiA from Mycobacterium Smegmatis, GDP Bound form
6uw7-assembly1_B 1.00 0.99 0.95 0.99 71% 100% / 100% 2.5e-55 sig 6uw7-assembly1_B The crystal structure of FbiA from Mycobacterium smegmatis, Dehydro-F420-0 bound form
6uvx-assembly1_B 1.00 0.99 0.96 0.99 72% 100% / 100% 4.8e-55 sig 6uvx-assembly1_B The crystal structure of FbiA from Mycobacterium Smegmatis, Apo state
6uw5-assembly1_A 1.00 0.96 0.93 0.96 72% 100% / 100% 2.2e-52 sig 6uw5-assembly1_A The crystal structure of FbiA from Mycobacterium smegmatis, GDP and Fo bound form

Foldseek search of the AlphaFold DB model (mean pLDDT 95.8, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 2

Upstream (5' on genome)whiB2 (- strand, 401 bp gap)
Downstream (3' on genome)fbiB (+ strand, -4 bp gap)
Predicted operon fbiA · fbiB

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton) — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3359) exponential phase: operon of 2, Rv3261 · Rv3262 (coverage 29.89)
not expressed (stationary phase) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Additional regulons (curated, outside the TFOE-derived TRN)

crp binding site only -- direction not determined (low confidence · CRP regulon (Kahramanoglou et al. 2014))
ChIP-seq : site de fixation CRP (1 des 191 sites de Kahramanoglou et al. 2014) ; aucun changement d'expression rapporte pour ce gene chez le mutant delta-crp
Caveat: Site de fixation CRP mesure par ChIP-seq (Kahramanoglou et al. 2014), SANS changement d'expression mesure pour ce gene chez le mutant delta-crp : le sens de la regulation n'est PAS determine. Ecrire « site de fixation CRP en amont », jamais « regule par CRP ». L'article ne distingue pas « non differentiellement exprime » de « sous le seuil », donc l'absence de ce gene de la table d'expression n'est pas une preuve de non-regulation. Pic divergent entre Rv3261 et Rv3260c : l'article ne tranche pas lequel des deux genes flanquants est la cible reelle. Les deux loci sont verses avec cette meme reserve.

Curated from primary literature not covered by the ISB signed TRN (Minch 2015 / Rustad 2014): Zur regulon (Maciag et al. 2007, PMID 17098899), SigG regulon (Gaudion et al. 2013, PMID 23871545), LexA/SOS regulon (Smollett et al. 2012, PMID 22528497) — added P16.25 (2026-08-18); CRP regulon (Kahramanoglou et al. 2014, PMID 24957601) — added P16.25b (2026-09-27). Confidence and caveats are per-edge and carried from the source paper — read them before citing a specific gene as "regulated by" its listed TF. An entry reading "binding site only — direction not determined" is not a regulation claim: it records a measured ChIP-seq binding site for which the source reports no expression change, and the absence of such a change is not evidence of absent regulation.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: fbiB (coenzyme F420:L-glutamate ligase), high confidence (score 999, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism.

Showing the 15 strongest of this gene's 56 partners at medium confidence (25 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 56 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3262 fbiB curated coenzyme F420:L-glutamate ligase 999 999 ctx neighborhood:882 cooccurence:773 coexpression:797 database:900 textmining:908
Rv2983 cofC curated 2-phospho-L-lactate guanylyltransferase 998 979 ctx cooccurence:773 database:900 textmining:948
Rv1173 fbiC curated FO synthase 997 975 ctx cooccurence:727 database:900 textmining:893
Rv3547 ddn deazaflavin-dependent nitroreductase 976 768 ctx cooccurence:762 textmining:903
Rv0132c fgd2 F420-dependent glucose-6-phosphate dehydrogenase 878 758 ctx cooccurence:750 textmining:520
Rv3178 nitroreductase 869 753 ctx cooccurence:746 textmining:493
Rv1558 hypothetical protein 835 751 ctx cooccurence:747
Rv3520c coenzyme F420-dependent oxidoreductase 763 750 ctx cooccurence:741
Rv1261c hypothetical protein 755 749 ctx cooccurence:747
Rv0407 fgd1 F420-dependent glucose-6-phosphate dehydrogenase 990 747 ctx cooccurence:728 textmining:965
Rv2951c phthiodiolone/phenolphthiodiolone dimycocerosates ketoreductase 760 747 ctx cooccurence:737
Rv3093c oxidoreductase 760 747 ctx cooccurence:739
Rv0044c oxidoreductase 742 729 ctx cooccurence:718
Rv1855c oxidoreductase 742 728 ctx cooccurence:716
Rv3263 DNA methylase 725 725 ctx neighborhood:718

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: 2-phospho-L-lactate transferase
  • MTBC0 PGAP product: 2-phospho-L-lactate transferase
  • Pfam (hmmscan --cut_ga): CofD PF01933.24 (E=3e-60)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_217778.1)
  • Domains: Pfam-A via hmmscan --cut_ga — CofD (PF01933.24)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0391
  • Curated reference: UniProt P9WP81 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 95.8)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 56 functional partner(s); context anchor fbiB
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_003469|Rv3261|fbiA
MKVTVLAGGVGGARFLLGVQQLLGLGQFAANSAHSDADHQLSAVVNVGDDAWIHGLRVCPDLDTCMYTLGGGVDPQRGWGQRDETWHAMQELVRYGVQPDWFELGDRDLATHLVRTQMLQAGYPLSQITEALCDRWQPGARLLPATDDRCETHVVITDPVDESRKAIHFQEWWVRYRAQVPTHSFAFVGAEKSSAATEAIAALADADIIMLAPSNPVVSIGAILAVPGIRAALREATAPIVGYSPIIGEKPLRGMADTCLSVIGVDSTAAAVGRHYGARCATGILDCWLVHDGDHAEIDGVTVRSVPLLMTDPNATAEMVRAGCDLAGVVA